Advanced search
Publication Cover
Leukemia & Lymphoma Volume 48, 2007 - Issue 8
Submit an article Journal homepage
65
Views
4
CrossRef citations to date
0
Altmetric
Letter to the Editor

Multiple myeloma and renal cell carcinoma possible association

Ashraf Badros University of Maryland, Greenebaum Cancer Center, Baltimore, MarylandCorrespondence[email protected]
, MD,
Joyson Karakunnel University of Maryland, Greenebaum Cancer Center, Baltimore, Maryland
&
Nancy Dawson University of Maryland, Greenebaum Cancer Center, Baltimore, Maryland
Pages 1662-1664 | Received 15 Feb 2007, Accepted 25 Apr 2007, Published online: 01 Jul 2009

References

  • Nishikubo C Y, Kunkel L A, Figlin R, Belldegrun A, Rosen P, Elashoff R, et al. An association between renal cell carcinoma and lymphoid malignancies. A case series of eight patients. Cancer 1996; 78: 2421–2426
  • Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun M J. Cancer statistics, 2007. CA Cancer J Clin 2007; 57: 43–66
  • Hayat M J, Howlader N, Reichman M E, Edwards B K. Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. Oncologist 2007; 12: 20–37
  • Isobe T, Osserman E F. Pathologic conditions associated with plasma cell dyscrasias: a study of 806 cases. Ann N Y Acad Sci 1971; 190: 507–518
  • Kurtz J E, Andres E, Maloisel F, Herbrecht R, Dufour P. Renal clear-cell adenocarcinoma and type B lymphomatous proliferation: a fortuitous association?. Rev Med Intern 1999; 20: 329–332
  • Morgan G J, Davies F E, Linet M. Myeloma aetiology and epidemiology. Biomed Pharmacother 2002; 56: 223–234
  • Lipworth L, Tarone R E, McLaughlin J K. The epidemiology of renal cell carcinoma. J Urol 2006; 176: 2353–2358
  • Aggarwal R, Ghobrial I M, Roodman G D. Chemokines in multiple myeloma. Exp Hematol 2006; 34: 1289–1295
  • Paule B, Belot J, Rudant C, Coulombel C, Abbou C C. The importance of IL-6 protein expression in primary human renal cell carcinoma: an immunohistochemical study. J Clin Pathol 2000; 53: 388–390
  • Sakai A, Kawano M, Kuramoto A. Interleukin-6 produced by renal-cell carcinoma cells and progression of multiple myeloma. N Engl J Med 1991; 324: 1893–1894
  • Choueiri T K, Dreicer R, Rini B I, Elson P, Garcia J A, Thakkar S G, et al. Phase II study of lenalidomide in patients with metastatic renal cell carcinoma. Cancer 2006; 107: 2609–2616
  • Kondagunta G V, Drucker B, Schwartz L, Bacik J, Marion S, Russo P, et al. Phase II trial of bortezomib for patients with advanced renal cell carcinoma. J Clin Oncol 2004; 22: 3720–3725
  • Juliusson G, Karlsson K, Malm C. More potent graft-versus-myeloma effect than graft-versus-renal cell cancer effect. Leuk Lymphoma 2002; 43: 2233–2234

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.